ARKOArko Corp.
Is the price fair?
Neither cheap nor expensive: modest expectations priced in, but well above its own median P/E.
Priced for a decline (~−1% a year). Little growth is priced in even as revenue fell 5% a year over three years, potential value, or a value trap.
Expensive vs its own history: P/E 51.5 vs a 28.8 median over 22 quarters (+79% vs median).
Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.
What ARKO's price assumes
Arko Corp. trades at 51.5× earnings against 19.5× for the median Specialty Retail name, more expensive than its own group.
Trailing P/E · Specialty Retail median 19.5 · 2.64× the median: the market pays up for this one
- Price / sales
- 0.08
Price / sales · as of 2026-Q1
- Free cash flow yield
- 8.0%
Free cash flow yield · Specialty Retail median 5.8%
- Growth the price implies
- −0.52%
Growth the price implies · The price pays for −0.52% free cash flow growth a year for a decade; the business has delivered −23% a year over the last three.
Details›
- Price / bookas of 2026-Q1
- 1.25
- EV / EBIToperating margin 1.2%: the multiple describes the denominator
- not meaningful
- EV / salesas of 2026-Q1
- 0.36
- Consumer Cyclical median P/E321 names
- 17.9
- Specialty Retail median P/E25 names
- 19.5
- Free cash flow, trailing twelve months
- $37M
- Market capitalisation
- $462M
- 3-year revenue growth
- −4.8%
- 3-year free cash flow growth
- −23%
| Method | Per share |
|---|---|
| Its own P/E history, lower quartile | $1.54 |
| Its own P/E history, median | $2.31 |
| Its own P/E history, upper quartile | $4.08 |
| 52-week range | $3.76 – $8.64 |
| Today | $4.12 |
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.